Injectable Drug Delivery Market

The Connected Injectable Drug Delivery Devices Market

By Materials, By Product, By Preparation Method, By Application and By Geography Analysis - Forecast 2019 - 2024 www.industryarc.com

sales@industryarc.com

The Connected Injectable Drug Delivery Devices Market 2019-2024

01

Industry Market Research for Business Leaders, Strategists, Decision Makers

Press Release According to the new market research report by IndustryARC titled “Connected Injectable Drug Delivery Devices Market: By Organic (Blood Meal, Fish Meal, Manure, Granite Meal, Others); By Inorganic (Nitrogen, Potassium, Phosphate, Calcium, Sulfur, Others); By Bio-Connected Injectable Drug Delivery Devices (PSB, Azotobacter, Others); By Crops (Wheat, Rice, Maize, Others); By GeographyConnected Injectable Drug Delivery Devices Market: By Type (Conventional, SelfInjection, Others); By Connected Technology (Wireless, Bluetooth, Apps, NFC); By Disease (Anaphylaxis, Cardiovascular, Diabetes, etc); By Geography – Forecast (2018-2023)”, the market is driven by the rising prevalence of chronic diseases like diabetes, cardiovascular diseases, and cancer.

Europe continues to lead the market share during 2018-2023.

Europe is dominating the global connected injectable drug delivery devices market. Europe selfinjection drug delivery devices market generated revenue of $1.125 billion in 2017, and is estimated to grow at a CAGR of 11.1% during the forecast period. Asia-Pacific is projected to register highest growth rate of 11.8% CAGR for self-injection drug delivery devices market, during the forecast period.

Rapidly aging population in the U.K. is propelling the growth of connected injectable drug delivery devices market.

Conventional injection devices segment dominated with $13.11 billion in 2017, and is estimated to reach $18.43 billion by 2023. Whereas, Self-injection devices segment is projected to register highest growth rate of 10.9% during the forecast period.

Selected / Sample Analysis done in the full Report: •In the value chain of injectable drug delivery devices, when the design, product features, specifications and patent filing are finished from the manufacturer’s end, the product is sent for production purposes.

•This is either done by the company which owns the product at their factories, or can be outsourced to other contract manufacturers in certain countries where it makes more economic sense to manufacture locally, rather than shipping it.

•The product is then packed and sent to the global distributors, which are supplied to local or regional distributors, pharmacy shops, hospitals and clinics.

Talk to one of our sales representative about the full report by providing your details in the below link: https://industryarc.com/support.php?id=18040 Excerpts on Market Growth Factors Mentioned in the Full Report: 1.Increase in global diabetic population and rising use of insulin pens is the major factor that is driving major growth.

2.Increasing attention of pharmaceutical or medical devices companies towards deployment of connectivity in injectable drug delivery devices is expected to propel the growth of connected injectable drug delivery devices.

3.Surge of biologics has been driving the injectable drug delivery technologies market, with 25 new medicines, which are due to be licensed for marketing in Germany for the year 2013 as mentioned by the German Association of Researched-Based Pharmaceutical Companies.

4.Greater accuracy, ease of use, patient satisfaction, quality of life, and extension of life expectancy are the driving factors for the connected injectable drug delivery devices market.

To access / purchase the full report browse the link below https://industryarc.com/Report/18040/connected-injectable-drug-delivery-devices-market.html

The Connected Injectable Drug Delivery Devices Market

02

Key Players of the Connected Injectable Drug Delivery Devices Market: The major players of the connected injectable drug delivery devices market are West Pharmaceutical Service, Inc., Ypsomed, Unilife Corporation, SHL Group and Bayer AG. Ypsomed introduces low-cost integrated sensor technology to detect the user status of the auto injector which is wirelessly transmitted to a smartphone using Near Field Communication (NFC). YpsoMate Smart also allows medical practitioners to monitor patient adherence and tailor their patient guidance and advice accordingly.

Related Reports: A.Injectable Drug Delivery Market https://industryarc.com/Report/1255/injectable-drug-delivery-market-analysis.html B.Therapeutic Drug Monitoring Market https://industryarc.com/Report/16821/therapeutic-drug-monitoring-market.html Media Contact: Mr. Venkat Reddy Sales Manager Email: sales@industryarc.com Contact Sales: +1-614-588-8538 (Ext-101) About IndustryARC: IndustryARC is a Research and Consulting Firm that publishes more than 500 reports annually, in various industries such as Agriculture, Automotive, Automation & Instrumentation, Chemicals and Materials, Energy and Power, Electronics, Food and Beverages, Information Technology, and Life sciences and Healthcare.

The Connected Injectable Drug Delivery Devices Market

03

Industry Market Research for Business Leaders, Strategists, Decision Makers

Table of Contents 1. Injectable Drug Delivery Market - Overview 1.1. Definitions and Scope 2. Injectable Drug Delivery Market - Executive summary 2.1. Market Revenue, Market Size and Key Trends by Company 2.2. Key Trends by type of Application 2.3. Key Trends segmented by Geography 3. Injectable Drug Delivery Market 3.1. Comparative analysis 3.1.1. Product Benchmarking - Top 10 companies 3.1.2. Top 5 Financials Analysis 3.1.3. Market Value split by Top 10 companies 3.1.4. Patent Analysis - Top 10 companies 3.1.5. Pricing Analysis 4. Injectable Drug Delivery Market – Startup companies Scenario 4.1. Top 10 startup company Analysis by 4.1.1. Investment 4.1.2. Revenue 4.1.3. Market Shares 4.1.4. Market Size and Application Analysis 4.1.5. Venture Capital and Funding Scenario 5. Injectable Drug Delivery Market – Industry Market Entry Scenario 5.1. Regulatory Framework Overview 5.2. New Business and Ease of Doing business index 5.3. Case studies of successful ventures 5.4. Customer Analysis – Top 10 companies 6. Injectable Drug Delivery Market Forces 6.1. Drivers 6.2. Constraints 6.3. Challenges 6.4. Porters five force model 6.4.1. Bargaining power of suppliers 6.4.2. Bargaining powers of customers 6.4.3. Threat of new entrants 6.4.4. Rivalry among existing players 6.4.5. Threat of substitutes 7. Injectable Drug Delivery Market - Strategic analysis 7.1. Value chain analysis 7.2. Opportunities analysis 7.3. Product life cycle 7.4. Suppliers and distributors Market Share 8. Injectable Drug Delivery Market – Market By Delivery Devices (Market Size -$Million / $Billion) 8.1. Market Size and Market Share Analysis 8.2. Application Revenue and Trend Research 8.3. Product Segment Analysis 8.3.1. Market Overview 8.3.2. Conventional Injection Devices Market 8.3.3. Self-Injection Devices Market 8.3.4. Auto Drug Injecting Devices 8.3.4.1. By Drug Loading

The Connected Injectable Drug Delivery Devices Market

04

8.3.4.1.1. Prefilled Auto Injectors 8.3.4.1.2. Fillable Auto Injectors 8.3.4.1.3. By User Intervention 8.3.4.1.4. Automated Auto Injectors 8.3.4.1.5. Manual Auto Injectors 8.3.4.1.6. By Design 8.3.4.1.6.1. Standard Auto Injectors 8.3.4.1.6.2. Customized Auto Injectors 8.3.4.1.7. By Reusability 8.3.4.1.7.1. Disposable Auto Injectors 8.3.4.1.7.2. Reusable Auto Injectors 8.3.5. Pen Injectors 8.3.5.1. By Product 8.3.5.1.1. Single Chamber Pen Injectors 8.3.5.1.2. Dual Chamber Pen Injectors 8.3.5.2. By Reusability 8.3.5.2.1. Disposable Pen Injectors 8.3.5.2.2. Reusable Pen Injectors 8.3.5.3. By Design 8.3.5.3.1. Standardized Pen Injectors 8.3.5.3.2. Customized Pen Injectors 8.3.6. Needle Free Drug Injection Devices 8.3.6.1. By Drug Loading 8.3.6.1.1. Prefilled Needle Free Injectors 8.3.6.1.2. Fillable Needle Free Injectors 8.3.6.2. By Technology 8.3.6.2.1. Jet-Based Needle-Free Injectors 8.3.6.2.2. Spring-Based Needle-Free Injectors 8.3.6.2.3. Laser-Based Needle Free Injectors 8.3.6.2.4. Vibration-Based Needle Free Injectors 8.3.6.3. By Reusability 8.3.6.3.1. Disposable Needle Free Injectors 8.3.6.3.2. Reusable Needle Free Injectors 8.3.7. Conventional Drug Injection Devices 8.3.7.1. By Reusability 8.3.7.1.1. Disposable Injection Devices 8.3.7.1.2. Reusable Injection Devices 8.3.7.2. By Material 8.3.7.2.1. Glass Based Injectors 8.3.7.2.2. Plastic Based Injectors 8.3.7.3. By Drug Loading 8.3.7.3.1. Prefilled Injection Devices 8.3.7.3.2. Fillable Injection Device 8.3.8. Wearable injectors 8.3.9. Safety syringes 8.3.10. Integrated safety syringes 8.3.11. Patch injectors 8.3.12. Subcutaneous infusion devices 9. Injectable Drug Delivery Market – By Drug Formulations (Market Size -$Million / $Billion) 9.1. Conventional Drug Delivery Formulations 9.1.1. Injectable Drug Delivery Formulation Solutions 9.1.2. Reconstituted Drug Delivery Formulation Solutions 9.2. Novel Drug Delivery Formulation Solutions 9.2.1. Liposomal Systems 9.2.2. Microspheres 9.2.3. Nanoparticles 9.2.4. Polymeric Micelles 9.2.5. Others

The Connected Injectable Drug Delivery Devices Market

05

10. Injectable Drug Delivery Market – By Therapeutic Areas (Market Size -$Million / $Billion) 10.1. Auto-Immune Diseases 10.1.1. Multiple Sclerosis 10.1.2. Rheumatoid Arthritis 10.1.3. Crohn's Diseases 10.1.4. Psoriasis 10.1.5. Others 10.2. Hormonal Disorders 10.2.1. Diabetes 10.2.2. Anemia 10.2.3. Reproductive Health Diseases 10.2.4. Osteoporosis 10.2.5. Growth Hormone Deficiency 10.2.6. Antithrombotic Therapy 10.3. Orphan or Rare Diseases 10.4. Oncology 10.5. Others 10.5.1. Pain Management 10.5.2. Hepatitis C 10.5.3. Allergies 10.5.4. Aesthetic Treatment 11. Injectable Drug Delivery Market – By application (Market Size -$Million / $Billion) 11.1. Diabetes 11.2. Cardiovascular diseases 11.3. Autoimmune diseases 11.4. Hormones replacement 11.5. Neurology addiction 11.6. Respiratory diseases 11.7. others 12. Injectable Drug Delivery – By End User(Market Size -$Million / $Billion) 12.1. Segment type Size and Market Share Analysis 12.2. Application Revenue and Trends by type of Application 12.3. Application Segment Analysis by Type 12.3.1. Homecare 12.3.2. Professional care 12.3.2.1. Hospitals 12.3.2.2. clinics 13. Injectable Drug Delivery - By Geography (Market Size -$Million / $Billion) 13.1. Injectable Drug Delivery Market - North America Segment Research 13.2. North America Market Research (Million / $Billion) 13.2.1. Segment type Size and Market Size Analysis 13.2.2. Revenue and Trends 13.2.3. Application Revenue and Trends by type of Application 13.2.4. Company Revenue and Product Analysis 13.2.5. North America Product type and Application Market Size 13.2.5.1. U.S. 13.2.5.2. Canada 13.2.5.3. Mexico 13.2.5.4. Rest of North America 13.3. Injectable Drug Delivery - South America Segment Research 13.4. South America Market Research (Market Size -$Million / $Billion) 13.4.1. Segment type Size and Market Size Analysis 13.4.2. Revenue and Trends 13.4.3. Application Revenue and Trends by type of Application 13.4.4. Company Revenue and Product Analysis 13.4.5. South America Product type and Application Market Size 13.4.5.1. Brazil 13.4.5.2. Venezuela

The Connected Injectable Drug Delivery Devices Market

06

13.4.5.3. Argentina 13.4.5.4. Ecuador 13.4.5.5. Peru 13.4.5.6. Colombia 13.4.5.7. Costa Rica 13.4.5.8. Rest of South America 13.5. Injectable Drug Delivery - Europe Segment Research 13.6. Europe Market Research (Market Size -$Million / $Billion) 13.6.1. Segment type Size and Market Size Analysis 13.6.2. Revenue and Trends 13.6.3. Application Revenue and Trends by type of Application 13.6.4. Company Revenue and Product Analysis 13.6.5. Europe Segment Product type and Application Market Size 13.6.5.1. U.K 13.6.5.2. Germany 13.6.5.3. Italy 13.6.5.4. France 13.6.5.5. Netherlands 13.6.5.6. Belgium 13.6.5.7. Spain 13.6.5.8. Denmark 13.6.5.9. Rest of Europe 13.7. Injectable Drug Delivery – APAC Segment Research 13.8. APAC Market Research (Market Size -$Million / $Billion) 13.8.1. Segment type Size and Market Size Analysis 13.8.2. Revenue and Trends 13.8.3. Application Revenue and Trends by type of Application 13.8.4. Company Revenue and Product Analysis 13.8.5. APAC Segment – Product type and Application Market Size 13.8.5.1. China 13.8.5.2. Australia 13.8.5.3. Japan 13.8.5.4. South Korea 13.8.5.5. India 13.8.5.6. Taiwan 13.8.5.7. Malaysia 14. Injectable Drug Delivery Market - Entropy 14.1. New product launches 14.2. M&A's, collaborations, JVs and partnerships 15. Injectable Drug Delivery Market – Industry / Segment Competition landscape 15.1. Market Share Analysis 15.1.1. Market Share by Country- Top companies 15.1.2. Market Share by Region- Top 10 companies 15.1.3. Market Share by type of Application – Top 10 companies 15.1.4. Market Share by type of Product / Product category- Top 10 companies 15.1.5. Market Share at global level- Top 10 companies 15.1.6. Best Practices for companies 16. Injectable Drug Delivery Market – Key Company List by Country 17. Injectable Drug Delivery Market Company Analysis 17.1. Market Share, Company Revenue, Products, M&A, Developments 17.2. Terumo Corp 17.3. Schott AG 17.4. SHL group 17.5. Owen Mumford ltd 17.6. Sanofi 17.7. Novo nordix 17.8. Company 8 17.9. Company 9 and more

The Connected Injectable Drug Delivery Devices Market

07

"*Financials would be provided on a best efforts basis for private companies" 18. Injectable Drug Delivery Market - Appendix 18.1. Abbreviations 18.2. Sources 19. Injectable Drug Delivery Market - Methodology 19.1. Research Methodology 19.1.1. Company Expert Interviews 19.1.2. Industry Databases 19.1.3. Associations 19.1.4. Company News 19.1.5. Company Annual Reports 19.1.6. Application Trends 19.1.7. New Products and Product database 19.1.8. Company Transcripts 19.1.9. R&D Trends 19.1.10. Key Opinion Leaders Interviews 19.1.11. Supply and Demand Trends

The Connected Injectable Drug Delivery Devices Market

08

Industry Market Research for Business Leaders, Strategists, Decision Makers

IndustryARC Solutions We cater to the pain points of our clients by providing the following solutions, which are targeted and address key issues specifically. Each of the business verticals is helpful to a client at various stages of their operational, managerial and strategic level plans.

Syndicate Reports and Consulting (SRC) 1. Provide high quality analytical syndicated reports with key market insights, strategies and market forecasts for a specific industry or vertical of the clients. Constant tracking of industries and relations with experts helps us to predict and publish reports before our competitors as well as meet client needs proactively.

Market Research and Data Analytics (MRDA) 2. Provide pure play data analytics services for ad-hoc and long-term engagement projects of clients with market research layered into the analysis. We are the only global company to offer this combination one-stop service to clients. Redundancies generally seen by procuring data, analytics services from multiple vendors is overcome by our solution.

Competitive Landscape Analysis (CLA) 3. Provide company financial analysis, market share analysis, competitive landscape insights and market movements to clients. This is one of the most important pain point and key request from majority of our clients, for which we use our proprietary methodologies to provide accurate CLA data.

Accelerated Business Development (ABD) 4. Connect clients with their customers on a global scale by acting as an outsourced sales team on behalf of the client. This is a unique tri-party engagement model to benefit the client and their customer, and acts as a business development scale up at an international level.

Market Intel Reports (MIR) 5. Provide one-stop venue with a searchable syndicate reports database from global companies available to clients. This augments our offerings exponentially and also assists in studying global client needs at an in-depth level.

The Connected Injectable Drug Delivery Devices Market

09

Industry Market Research for Business Leaders, Strategists, Decision Makers

About IndustryARC IndustryARC strategy studies primarily focuses on Cutting Edge Technologies and Newer Applications of the Market. Our Custom Research Services are designed to provide insights on the constant flux in the global demand-supply gap of markets. Our strong analyst team enables us to meet the client research needs at a very quick speed with a variety of options for your business.

We look forward to support the client to be able to better address customer needs; stay ahead in the market; become the top competitor and get real-time recommendations on business strategies and deals.

We Work for You For IndustryARC, we value every customer equally. We only stay ready to help each client in the best way possible with a unique 24x365 support plan.

We suggest looking at the following benefits of relying on Professional Business Consulting and Custom Market Research Services to realize the unique strategic gains on offer: 1.

2.

3.

4.

5.

6.

7.

Strengthen and improve organizational performance Strategic planning and analysing Adoption of newer and cost-effective technologies Become environmentally sustainable and profitable Improve their training and certification procedures.

Planning for business automation.

Project facilitation and management.

Our Expertise Agriculture | Automotive | Energy and Power | Food & Beverage | Chemicals & Materials | Semiconductor & Electronics | Information Technology | Automation & Instrumentation Consumer Products & Services | Life Sciences and Healthcare

The Connected Injectable Drug Delivery Devices Market

010

The Connected Injectable Drug Delivery Devices Market

011